Page 6 - பிராங்க்ஃபர்ட் ஸ்டாக் பரிமாற்றம் ப்ரைம் தரநிலை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பிராங்க்ஃபர்ட் ஸ்டாக் பரிமாற்றம் ப்ரைம் தரநிலை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பிராங்க்ஃபர்ட் ஸ்டாக் பரிமாற்றம் ப்ரைம் தரநிலை Today - Breaking & Trending Today

Biofrontera reports results for the 2020 financial year


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Biofrontera reports results for the 2020 financial year
Biofrontera AGApril 12, 2021 GMT
Leverkusen, Germany, April 12, 2021 (GLOBE NEWSWIRE) Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its consolidated results for the fiscal year ended December 31, 2020. At the same time, the Company provided an overview of current operational and clinical developments.
Key financial figures FY2020
Revenue decreased by 3% to EUR 30.3 million compared to EUR 31.3 million in 2019;
Loss from operations amounted to EUR 7.6 million compared to a loss of EUR 23.4 million in 2019; ....

United States , United Kingdom , Baltic States , Biofrontera Pharma Gmb , Pamela Keck , Biofrontera Inc , European Commission , Drug Administration , Frankfurt Stock Exchange Prime Standard , Frankfurt Stock Exchange , American Academy Of Dermatology , European Medicines Agency , Biofrontera Group , Maruho Co Ltd , Committee For Medicinal Products Human Use , East Asia , American Academy , Biofrontera Pharma Gmbh , Medicinal Products , Human Use , Investor Relations , Prime Standard , Looking Statements , Private Securities Litigation Reform Act , Registration Statement , Public Health ,

PAION ANNOUNCES PRODUCT LAUNCH OF BYFAVO (REMIMAZOLAM) IN SOUTH KOREA BY HANA PHARM


PAION ANNOUNCES PRODUCT LAUNCH OF BYFAVO (REMIMAZOLAM) IN SOUTH KOREA BY HANA PHARM
DGAP-News: PAION AG
/ Key word(s): Market launch
07.04.2021 / 09:00
PAION ANNOUNCES PRODUCT LAUNCH OF BYFAVO
TM (REMIMAZOLAM) IN SOUTH KOREA BY HANA PHARM
Aachen (Germany), 07 April 2021 - The Specialty Pharma Company PAION AG (PA8; ISIN DE000A0B65S3; Frankfurt Stock Exchange Prime Standard) today announces that Hana Pharm, remimazolam licensee for South Korea, informed PAION about the launch of Byfavo
TM (remimazolam) for the use in general anesthesia in South Korea.
Remimazolam was approved in South Korea for general anesthesia in January 2021 and will be marketed under the brand name Byfavo ....

South Korea , South Korean , Yichang Humanwell , Hana Pharm , Ralf Penner , Jim Phillips , Specialty Pharma Company , Frankfurt Stock Exchange Prime Standard , Distribution Services , Chief Executive Officer , Acacia Pharma , Southeast Asia , Western Europe , Corporate News , Regulatory Announcements , தெற்கு கொரியா , தெற்கு கொரியன் , ஹனா பார்ம் , ரால்ஃப் பென்னர் , ஜிம் பிலிப்ஸ் , சிறப்பு பார்மா நிறுவனம் , பிராங்க்ஃபர்ட் ஸ்டாக் பரிமாற்றம் ப்ரைம் தரநிலை , விநியோகம் சேவைகள் , தலைமை நிர்வாகி அதிகாரி , தென்கிழக்கு ஆசியா , மேற்கு யூரோப் ,

SHOP APOTHEKE EUROPE: Fast growth continues, Q1 revenues up 22.5%.


SHOP APOTHEKE EUROPE: Fast growth continues, Q1 revenues up 22.5%.
DGAP-News: SHOP APOTHEKE EUROPE N.V.
/ Key word(s): Development of Sales/Preliminary Results
07.04.2021 / 07:00
SHOP APOTHEKE EUROPE: Fast growth continues, Q1 revenues up 22.5%.
Preliminary sales growth of 22.5% in Q1 to EUR 284 million.
DACH segment +15%, International segment +71%.
Total number of active customers up 0.5 million in Q1 to 6.8 million (year-over-year up 1.8 million).
Venlo, 7 April 2021. SHOP APOTHEKE EUROPE N.V. continued to grow dynamically in the first three months of the 2021 financial year. According to preliminary unaudited calculations, total group sales rose by 22.5% to EUR 284 million after EUR 232 million in Q1 last year.
Stefan Feltens, CEO of SHOP APOTHEKE EUROPE, comments: We are proud that we gained another record number of new customers across Europe. We achieved this despite the absence of a cold and flu season as a result of Covid-related s ....

France General , Noord Brabant , Sven Schirmer , Stefan Feltens , Thomas Schnorrenberg , Carmen Herkenrath , Frankfurt Stock Exchange Prime Standard , Management Board , Frankfurt Stock Exchange , Prime Standard , பிரான்ஸ் ஜநரல் , நூற்த் துணிச்சலான , ஸ்வெந் ஸ்கிர்மர் , பிராங்க்ஃபர்ட் ஸ்டாக் பரிமாற்றம் ப்ரைம் தரநிலை , மேலாண்மை பலகை , பிராங்க்ஃபர்ட் ஸ்டாக் பரிமாற்றம் , ப்ரைம் தரநிலை ,